Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Acg Pharma Technologies Private Limited, was an unlisted private company incorporated on 17 December, 1996. It is classified as a private limited company and is located in , Maharashtra. It's authorized share capital was INR 126.20 cr and the total paid-up capital was INR 122.29 cr.
Acg Pharma Technologies's operating revenue range is INR 100 cr - 500 cr for the financial year ending on 31 March, 2023. It's book networth has decreased by 19.44%.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2023 numbers.
-28.31%
-1145.41%
-19.44%
-12.86%
-1.45
-25.87
-25.21
-26.0
-39.74
No Reports Available
Tofler currently has no financial reports
for this company due to a lack of available
information. This may be because the company
is dormant or closed (see company status)
or because it was formed only recently
(check the incorporation date) and financial data
is not yet available.
You can view basic information by scrolling through the page.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(3)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Karan Jasjit Singh | 00901342 | 12 years |
| Director | Jasjit Daljit Singh | 00901470 | 28 years |
| Director | Ajit Daljit Singh | 00915347 | 28 years |
| Whole-time Director | Shaju Kunjuvareed Thommana | 08587951 | 5 years |
| CS | Rashmi Mishra | <HIDDEN> | 5 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| ACG METALCRAFTS PRIVATE LIMITED |
Amalgamated
|
159.1 Cr | 3 | Maharashtra |
| SCI-TECH CENTRE |
Active
|
0.0 | 2 | Maharashtra |
| ACG AJAS COMPONENTS PRIVATE LIMITED |
Amalgamated
|
5.0 L | 3 | Maharashtra |
| IQGEN-X PHARMA PRIVATE LIMITED |
Active
|
1.1 Cr | 1 | Maharashtra |
| ACG ARTS AND PROPERTIES PRIVATE LIMITED |
Active
|
17.0 Cr | 2 | Maharashtra |
| ACG CARES FOUNDATION |
Active
|
0.0 | 2 | Maharashtra |
| ACG PAMPAC MACHINES PRIVATE LIMITED |
Amalgamated
|
2.2 Cr | 3 | Maharashtra |
| ACG REAL ESTATE PRIVATE LIMITED |
Active
|
77.3 Cr | 1 | Maharashtra |
| BTF LAB PRIVATE LIMITED |
Active
|
1.0 Cr | 2 | Maharashtra |
| ACG SPORTS PRIVATE LIMITED |
Active
|
23.1 Cr | 2 | Maharashtra |
| ACG CELLULOSE PRIVATE LIMITED |
Active
|
63.5 Cr | 2 | Maharashtra |
| ACG GELATIN PRIVATE LIMITED |
Active
|
10.0 L | 1 | Maharashtra |
| ACG VALUE LINKS LLP |
Active
|
1.5 L | 3 | Maharashtra |
| ACG PHARMAGENTS LLP |
Active
|
2.0 L | 3 | Maharashtra |
| GLOBESCAN ENTERPRISES LLP |
Active
|
73.0 L | 3 | Maharashtra |
| VANTAGE NUTRITION LLP |
Active
|
50,000.0 | 2 | Maharashtra |
| ACG UNIVERSAL CAPSULES PRIVATE LIMITED |
Active
|
115.0 Cr | 2 | Maharashtra |
| ACG INSPECTION SYSTEMS PRIVATE LIMITED |
Active
|
5.5 Cr | 3 | Maharashtra |
| ACG ASSOCIATED CAPSULES PRIVATE LIMITED |
Active
|
28.2 L | 3 | Maharashtra |
| ACG PHARMAPACK PRIVATE LIMITED |
Active
|
50.8 Cr | 3 | Maharashtra |
| ACG PAM PHARMA TECHNOLOGIES PRIVATE LIMITED |
Active
|
172.0 Cr | 3 | Maharashtra |
| EMELL AUDHOWAGIK SAMSHODHAN NIGAM PRIVATE LIMITED |
Strike Off
|
200.0 | 2 | Maharashtra |
| PACKSHIELD INDIA PRIVATE LIMITED |
Amalgamated
|
1.0 Cr | 2 | Maharashtra |
| PAM INDTECH MACHINES PRIVATE LIMITED |
Amalgamated
|
121.2 Cr | 2 | Maharashtra |
| ACG KORSCH COMPRESSION TECHNOLOGIES PRIV ATE LIMITED |
Strike Off
|
1.0 L | 2 | Maharashtra |
| ORIND ESTATES PRIVATE LIMITED |
Amalgamated
|
17.2 L | 2 | Maharashtra |
| EVITA ESTATES PRIVATE LIMITED |
Amalgamated
|
10.1 L | 2 | Maharashtra |
| ADHIKAR TRADING PRIVATE LIMITED |
Amalgamated
|
22.2 L | 2 | Maharashtra |
| JEET MERCANTILE PRIVATE LIMITED |
Amalgamated
|
25.6 L | 2 | Maharashtra |
| CUSTOM CAPSULES PRIVATE LIMITED |
Active
|
1.0 Cr | 2 | Maharashtra |
| INTERNATIONAL PHARMACEUTICAL EXCIPIENTS' COUNCIL OF INDIA |
Active
|
0.0 | 1 | Maharashtra |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| Xertecs GmbH | Germany | - | - |
The incorporation date of ACG PHARMA TECHNOLOGIES PRIVATE LIMITED is 17 December, 1996
The authorized share capital of ACG PHARMA TECHNOLOGIES PRIVATE LIMITED is INR ₹ 126.2 Cr.
The paid-up capital of ACG PHARMA TECHNOLOGIES PRIVATE LIMITED is INR ₹ 122.3 Cr.
The registered address of ACG PHARMA TECHNOLOGIES PRIVATE LIMITED is 1001 DALAMAL HOUSE 10TH FLOORNARIMAN PO NA MUMBAI Maharashtra - 400021
The CIN number of ACG PHARMA TECHNOLOGIES PRIVATE LIMITED is U29251MH1996PTC104558.
Expand
Delete
Collapse
See
details
